SID85285640

ID: ALA1314048

Chembl Id: CHEMBL1314048

Cas Number: 109635-38-3

PubChem CID: 743900

Max Phase: Preclinical

Molecular Formula: C14H12ClN3

Molecular Weight: 257.72

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Nc1nc2ccccc2n1Cc1ccc(Cl)cc1

Standard InChI:  InChI=1S/C14H12ClN3/c15-11-7-5-10(6-8-11)9-18-13-4-2-1-3-12(13)17-14(18)16/h1-8H,9H2,(H2,16,17)

Standard InChI Key:  HKBJSDNECZUKSR-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA1314048

   1-(4-Chlorophenylmethyl)-2-aminobenzimidazole

Molecule Features

Natural Product: Yes

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 257.72

Molecular Weight (Monoisotopic): 257.0720

AlogP: 3.32

#Rotatable Bonds: 2

Polar Surface Area: 43.84

Molecular Species: NEUTRAL

HBA: 3

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 3

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 7.59

CX LogP: 3.67

CX LogD: 3.28

Aromatic Rings: 3

Heavy Atoms: 18

QED Weighted: 0.77

Np Likeness Score: -1.41

References

1. PubChem BioAssay data set, 

2. PubChem BioAssay data set, 

3. Hevener KE, Mehboob S, Su PC, Truong K, Boci T, Deng J, Ghassemi M, Cook JL, Johnson ME..  (2012)  Discovery of a novel and potent class of F. tularensis enoyl-reductase (FabI) inhibitors by molecular shape and electrostatic matching.,  55  (1): [PMID:22098466] [10.1021/jm201168g]

4. Khan PM, Correa RG, Divlianska DB, Peddibhotla S, Sessions EH, Magnuson G, Brown B, Suyama E, Yuan H, Mangravita-Novo A, Vicchiarelli M, Su Y, Vasile S, Smith LH, Diaz PW, Reed JC, Roth GP..  (2011)  Identification of Inhibitors of NOD1-Induced Nuclear Factor-κB Activation.,  2  (10): [PMID:22003428] [10.1021/ml200158b]

5. Vlaovic D, Canadanovic-Brunet J, Balaz J, Juranic I, Djokovic D, Mackenzie K.  (1992)  Synthesis, AntiBacteriol, and Antifungal Activities of Some New Benzimidazoles,  56  (2): [10.1271/bbb.56.199]

6. Jakopin Ž..  (2014)  Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway.,  57  (16): [PMID:24707857] [10.1021/jm401841p]

7. Keček Plešec K, Urbančič D, Gobec M, Pekošak A, Tomašič T, Anderluh M, Mlinarič-Raščan I, Jakopin Ž..  (2016)  Identification of indole scaffold-based dual inhibitors of NOD1 and NOD2.,  24  (21): [PMID:27601373] [10.1016/j.bmc.2016.08.044]

8. Antonova-Koch Y, Meister S, Abraham M, Luth MR, Ottilie S, Lukens AK, Sakata-Kato T, Vanaerschot M, Owen E, Jado JC, Maher SP, Calla J, Plouffe D, Zhong Y, Chen K, Chaumeau V, Conway AJ, McNamara CW, Ibanez M, Gagaring K, Serrano FN, Eribez K, Taggard CM, Cheung AL, Lincoln C, Ambachew B, Rouillier M, Siegel D, Nosten F, Kyle DE, Gamo FJ, Zhou Y, Llinás M, Fidock DA, Wirth DF, Burrows J, Campo B, Winzeler EA..  (2018)  Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.,  362  (6419): [PMID:30523084] [10.1126/science.aat9446]

9. Sarkar D, Olejniczak ET, Phan J, Coker JA, Sai J, Arnold A, Beesetty Y, Waterson AG, Fesik SW..  (2020)  Discovery of Sulfonamide-Derived Agonists of SOS1-Mediated Nucleotide Exchange on RAS Using Fragment-Based Methods.,  63  (15): [PMID:32673492] [10.1021/acs.jmedchem.0c00511]

Source

Source(3):

• Scientific Literature
• PubChem BioAssays
• Winzeler Lab Plasmodium Screening Data